Kewaunee Scientific Corp. Enters New Agreement, Terminates Old

Ticker: KEQU · Form: 8-K · Filed: Dec 4, 2025 · CIK: 55529

Kewaunee Scientific CORP /De/ 8-K Filing Summary
FieldDetail
CompanyKewaunee Scientific CORP /De/ (KEQU)
Form Type8-K
Filed DateDec 4, 2025
Risk Levelmedium
Pages3
Reading Time4 min
Key Dollar Amounts$2.50, $10.0 million, $23.0 million
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, debt-obligation, filing

TL;DR

Kewaunee Scientific just signed a new deal and ditched an old one, creating new debt.

AI Summary

On December 4, 2025, Kewaunee Scientific Corp. entered into a material definitive agreement and simultaneously terminated a prior material definitive agreement. The company also created a direct financial obligation. This filing is a current report under the Securities Exchange Act of 1934.

Why It Matters

This filing indicates a significant change in Kewaunee Scientific's contractual obligations, potentially impacting its financial structure and future operations.

Risk Assessment

Risk Level: medium — Changes in material definitive agreements and the creation of new financial obligations introduce uncertainty and potential financial risk.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by Kewaunee Scientific Corp. on December 4, 2025?

The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the excerpt.

What was the previous material definitive agreement that Kewaunee Scientific Corp. terminated?

The filing states that a material definitive agreement was terminated, but the identity or terms of this prior agreement are not specified in the provided text.

What type of direct financial obligation was created by Kewaunee Scientific Corp.?

The filing confirms the creation of a direct financial obligation, but the specific details or amount of this obligation are not disclosed in the excerpt.

What is the significance of filing a Form 8-K?

A Form 8-K is a Current Report filed with the SEC to announce major corporate events that shareholders should know about.

When was Kewaunee Scientific Corp. incorporated and in which state?

Kewaunee Scientific Corp. was incorporated in Delaware, as indicated by the filing.

Filing Stats: 998 words · 4 min read · ~3 pages · Grade level 11.4 · Accepted 2025-12-04 16:59:35

Key Financial Figures

Filing Documents

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. On December 4, 2025, Kewaunee Scientific Corporation (the "Company") entered into a First Amendment to Loan Agreement (the "First Amendment") with PNC Bank, National Association ("PNC"). The First Amendment amends the Loan Agreement, dated as of November 1, 2024 (the "Loan Agreement"), between the Company and PNC to, among other things, (i) permit the Company to repay in full the outstanding principal balances of the subordinated seller notes issued by the Company in connection with its acquisition of Nu Aire, Inc. ("Nu Aire") in November 2024 (collectively, the "Seller Notes"), together with all accrued but unpaid interest thereon (the "Seller Note Repayment"), (ii) provide for an additional $10.0 million term loan the proceeds of which are to be used by the Company to partially fund the Seller Note Repayment, and (iii) permit the Company to draw and use available funds under the revolving line of credit established by the Loan Agreement to partially fund the Seller Note Repayment. The foregoing summary of the First Amendment does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the First Amendment filed as Exhibit 10.1 of this Current Report on Form 8-K, which is incorporated by reference into this Item 1.01.

02 Termination of a Material Definitive Agreement

Item 1.02 Termination of a Material Definitive Agreement. On December 4, 2025, the Company completed the Seller Note Repayment. The Seller Notes were entered into on November 1, 2024 by and between the Company and each of Richard A. Peters, William F. Peters, Rita Peters Revocable Trust, and any amendments thereto, Richard A. Peters Revocable Trust, and any amendments thereto, Karan A. Peters Revocable Trust, William F. Peters 2023 Irrevocable Trust dated December 20, 2023, and any amendments thereto, and William F. Peters Revocable Trust, and any amendments thereto (collectively, the "Sellers"), in connection with the Company's acquisition of Nu Aire from the Sellers. The Seller Notes had an original outstanding principal balance of $23.0 million and accrued interest at 8% per annum . The Seller Notes were scheduled to mature on November 1, 2027. Pursuant to the terms of the Seller Notes, the Seller Notes could be prepaid, in full or in part, at any time without prepayment penalty, premium or other fee. Upon completion of the Seller Note Repayment, all obligations, covenants, debts and liabilities of the Company under the Seller Notes were satisfied and discharged in full, and the Seller Notes and all other documents entered into in connection with the Seller Notes were terminated. Item2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth under Item 1.01 above is hereby incorporated by reference into this Item 2.03.

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On December 4, 2025, the Company issued a press release announcing the entrance into the First Amendment and the completion of the Seller Note Repayment. A copy of the press release is attached hereto as Exhibit 99.1. The information under Item 7.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. The information in this Item 7.01 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 First Amendment to Loan Agreement, dated December 4, 2025, by and between Kewaunee Scientific Corporation and PNC Bank, National Association. 99.1 Press Release of Kewaunee Scientific Corporation dated December 4, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. KEWAUNEE SCIENTIFIC CORPORATION (Registrant) Date: December 4, 2025 By /s/ Donald T. Gardner III Donald T. Gardner III Vice President, Finance Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing